4
Y. Yamada et al. / Tetrahedron xxx (2015) 1e5
118.1, 117.2, 112.7, 110.1, 51.8, 48.2, 33.3, 29.8, 22.6, 13.0, 12.7; HRMS
1.9 mmol) in anhydrous CHCl3 (55 mL) at 0 ꢀC. After being stirred at
rt for 16 h, the reaction was quenched with satd Na2S2O5 aq The
aqueous layer was extracted with ethyl acetate for three times. The
combined organic layers were washed with satd NaHCO3 aq and
brine, dried over anhydrous MgSO4, and concentrated in vacuo. The
residue was purified by MPLC to give the title compound (0.76 g,
96%) as a colorless oil, Rf 0.11 (hexane/ethyl acetate¼10:1). 1H NMR
(EI) calcd for C15H20N2O2: Mþ, 260.1525. Found: m/z 260.1516.
3.4. Intramolecular heteroarylcyanation of 3 catalyzed by
nickel/AlMe2Cl
To
a solution of Ni(cod)2 (13.8 mg, 50 mmol) and P(4-
MeOeC6H4)3 (53 mg, 0.15 mmol) dissolved in toluene (1.0 mL)
prepared in a 3 mL vial in a dry box were added 3 (0.26 g,1.0 mmol),
a 1.04 M solution of AlMe2Cl in hexane (96 mL, 0.10 mmol), and
undecane (internal standard, 57 mg, 0.33 mmol) sequentially. The
vial was sealed with a screw-cap, taken outside the dry box, and
heated at 100 ꢀC for 5 h. The resulting mixture was filtered through
a silica gel pad, and then concentrated in vacuo. The residue was
purified by MPLC to give 2 (0.21 g, 81%) and 5 (26 mg, 11%).
(400 MHz, CDCl3)
d
7.09 (s,1H), 4.40 (dt, J¼13.5, 5.8 Hz,1H), 4.26 (dt,
J¼13.5, 7.0 Hz, 1H), 3.77 (s, 3H), 3.65 (s, 3H), 2.68e2.53 (m, 1H),
2.27e2.00 (m, 3H), 1.98e1.49 (m, 6H), 0.80 (t, J¼7.5 Hz, 3H); 13C
NMR (101 MHz, CDCl3) d 174.0, 160.6, 139.9, 126.9, 122.6, 57.8, 51.7,
51.1, 46.1, 39.4, 33.2, 31.4, 29.7, 28.5, 20.3, 8.6. 1H NMR and 13C NMR
spectra were identical to those reported in the literature.11f
3.7. Methyl 1-{2-[(tert-butoxycarbonyl)amino]phenyl-8-
ethyl-8-(3-methoxy-3-oxopropyl)-5,6,7,8-
3.4.1. Methyl 8-(2-cyanoethyl)-8-ethyl-5,6,7,8-tetrahydroindolizine-
tetrahydroindolizine-3-carboxylate (7)11f
3-carboxylate (2). A colorless oil, Rf 0.23 (hexane/ethyl
acetate¼3:1). 1H NMR (400 MHz, CDCl3)
d
6.94 (d, J¼4.0 Hz, 1H),
Pd2(dba)3 (3.3 mg, 3.7
dimethoxybiphenyl (SPhos, 6.0 mg, 14.6
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbamate
(93 mg, 0.29 mmol) were placed in a 15 mLevial. The vial was
transferred into a dry box, and K3PO4 (0.12 g, 0.58 mmol) and
m
mol), 2-dicyclohexylphosphino-20,60-
mol), and tert-butyl-N-[2-
5.90 (d, J¼4.0 Hz, 1H), 4.37e4.23 (m, 2H), 3.78 (s, 3H), 2.26e2.17 (m,
m
2H), 2.06e2.00 (m, 4H),1.81e1.68 (m, 4H), 0.83 (t, J¼7.5 Hz, 3H); 13
C
NMR (101 MHz, CDCl3)
d 161.6, 140.8, 121.1, 120.0, 117.6, 105.7, 50.9,
45.1, 38.3, 35.7, 33.3, 28.7, 19.8, 12.8, 8.4; HRMS (EI) calcd for
C
15H20N2O2: Mþ, 260.1525. Found: m/z 260.1524.
a 0.90 M solution of 6 in THF (163 mL, 0.15 mmol) were added se-
quentially to the vial. The vial was sealed with a screw-cap, and
taken outside the dry box. To the vial were added THF (5.8 mL) and
degassed water (1.5 mL). After being stirred at rt for 1 h and then at
40 ꢀC for 40 h, the reaction was quenched with satd NH4Cl aq. The
aqueous layer was extracted with ethyl acetate for three times. The
combined organic layers were washed with satd NaHCO3 aq, dried
over anhydrous MgSO4, and concentrated in vacuo. The residue was
purified by MPLC to give the title compound (49 mg, 69%) as a 3:2
mixture of rotamers as a brownish oil, Rf 0.18 (hexane/ethyl
3.4.2. Methyl 8-ethyl-8-vinyl-5,6,7,8-tetrahydroindolizine-3-
carboxylate (5). A colorless oil, Rf 0.46 (hexane/ethyl
acetate¼10:1). 1H NMR (400 MHz, CDCl3)
d
6.97 (d, J¼4.0 Hz, 1H),
5.97 (d, J¼4.0 Hz,1H), 5.83 (dd, J¼17.3,10.5 Hz,1H), 5.04 (dd, J¼10.4,
0.7 Hz,1H), 4.72 (dd, J¼17.3, 0.8 Hz,1H), 4.58 (dt, J¼13.7, 4.5 Hz,1H),
4.05e3.94 (m, 1H), 3.78 (s, 3H), 2.13e1.84 (m, 2H), 1.79e1.67 (m,
4H), 0.85 (t, J¼7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3)
d 161.7, 145.2,
141.6, 120.5, 117.5, 113.9, 106.5, 50.8, 45.5, 43.1, 33.8, 28.8, 19.5, 8.5;
HRMS (EI) calcd for C14H19NO2: Mþ, 233.1416. Found: m/z 233.1415.
acetate¼5:1). 1H NMR (400 MHz, CDCl3)
d
8.17 (d, J¼9.0 Hz, 0.4H),
8.09 (d, J¼8.2 Hz, 0.6H), 7.30 (t, J¼7.4 Hz, 1H), 7.12 (d, J¼7.3 Hz, 1H),
6.96 (t, J¼7.4 Hz, 1H), 6.81 (s, 0.4H), 6.80 (s, 0.6H), 6.44 (s, 0.4H),
6.31 (s, 0.6H), 4.54e4.40 (m, 1H), 4.38e4.21 (m, 1H), 3.80 (s, 3H),
3.63 (s, 1.8H), 3.56 (s, 1.2H), 2.32e1.22 (m, 19H), 0.82e0.67 (m, 3H);
3.5. Methyl 8-ethyl-8-(3-methoxy-3-oxopropyl)-5,6,7,8-
tetrahydroindolizine-3-carboxylate (1)11f
A solution of 2 (0.21 g, 0.81 mmol) and KOH (1.2 g, 21.4 mmol) in
MeOH (1.8 mL) and water (2.4 mL) was heated at the reflux tem-
perature for 16 h. After being cooled at 0 ꢀC, the resulting solution
was acidified with 1 M HCl aq, and the aqueous layer was extracted
with CH2Cl2 for three times. The combined organic layers were dried
over anhydrous MgSO4 and concentrated until the volume became
about 3 mL. The residue and N,N0-dicyclohexylcarbodiimide (0.67 g,
3.2 mmol) were sequentially added to a solution of N,N-dimethyl-4-
aminopyridine (15 mg, 0.12 mmol) in anhydrous CH2Cl2 (10.8 mL)
and anhydrous MeOH (3.6 mL) at rt under an argon atmosphere.
After being stirred at rt for 21 h, the resulting solution was diluted
with water. The aqueous layer was extracted with CH2Cl2 for three
times. The combined organic layers were dried over anhydrous
MgSO4 and concentrated in vacuo. The residue was purified by MPLC
to give the title compound (0.13 g, 53%) as a colorless oil, Rf 0.21
13C NMR (101 MHz, CDCl3)
d 173.7, 173.6, 161.5, 161.4, 152.44, 152.37,
139.9, 139.4, 137.2, 131.2, 131.1, 128.53, 128.49, 125.5, 125.3, 121.8,
121.6, 120.8, 120.1, 119.9, 118.2, 117.9, 116.2, 116.0, 80.3, 51.6, 51.0,
45.8, 45.7, 40.1, 35.7, 34.0, 33.6, 33.3, 30.2, 29.9, 29.7, 28.8, 28.30,
28.26, 28.21, 21.0, 20.4, 9.4, 9.1. 1H NMR and 13C NMR spectra were
identical to those reported in the literature.11f
3.8. Rhazinilam11f
Ba(OH)2$8H2O (1.5 g, 4.9 mmol) was added to a solution of 7
(94 mg, 0.19 mmol) in MeOH. After being stirred at rt for 2 h, the
solution was acidified with 1 M HCl aq The aqueous layer was
extracted with ethyl acetate for three times. The combined organic
layers were washed with water, dried over anhydrous MgSO4, and
concentrated in vacuo. The residue was dissolved in CH2Cl2 (3.0 mL)
and trifluoroacetic acid (6.1 mL), and the mixture was stirred at rt
for 1 h before concentration in vacuo to give a brown oil. The crude
product was dissolved in anhydrous CH2Cl2 (23 mL) and added
dropwise over 17 h to a stirred solution of O-(7-azabenzotiazol-1-
yl)-N,N,N0,N0-tetramethyluronium hexafluorophosphate (HATU,
0.22 g, 0.58 mmol) and N,N0-diisopropylethylamine (0.13 g,
0.97 mmol) in anhydrous DMF (38 mL) and CH2Cl2 (15 mL). After
being stirred at rt for additional 4 h, the resulting solution was
diluted with water. The aqueous layer was extracted with ethyl
acetate for three times. The combined organic layers were washed
with 1 M HCl aq, 1 M NaOH aq, brine, and NaHCO3 aq, dried over
anhydrous MgSO4, and concentrated in vacuo. The residue was
passed through MPLC to give crude 8 (55 mg, w81%). Crude 8
(hexane/ethyl acetate¼5:1). 1H NMR (400 MHz, CDCl3)
d 6.93 (d,
J¼4.0 Hz, 1H), 5.92 (d, J¼4.2 Hz, 1H), 4.29 (t, J¼6.2 Hz, 2H), 3.77 (s,
3H), 3.63 (s, 3H), 2.32e2.10 (m, 2H), 2.05e1.85 (m, 4H),1.76e1.49 (m,
4H), 0.82 (t, J¼7.4 Hz, 3H); 13C NMR (101 MHz, CDCl3)
d 174.2, 161.7,
142.6, 120.5, 117.6, 105.8, 51.6, 50.8, 45.1, 38.0, 34.9, 33.5, 29.6, 29.0,
19.9, 8.5. 1H NMR and 13C NMR spectra of the title compound were
identical to those reported in the literature.11f
3.6. Methyl 8-ethyl-1-iodo-8-(3-methoxy-3-oxopropyl)-
5,6,7,8-tetrahydroindolizine-3-carboxylate (6)11f
Silver trifluoroacetate (0.50 g, 2.3 mmol) and iodine (0.58 g,
2.3 mmol) were added sequentially to a solution of 1 (0.55 g,